Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy, Biologic therapy.

Zhengzhou University Affiliated Cancer Hospital, Henan, China.

Survival: monthsCountry:China
Toxiciy Grade:3City/State/Province:Henan
Treatments:Chemotherapy, Biologic therapyHospital:Zhengzhou University Affiliated Cancer Hospital
Drugs:Journal:Link
Date:Jan 2015

Description:

Patients:
This study involved 52 advanced epithelial ovarian cancer patients who had received previous platinum- or taxane-based chemotherapy. The median patient age was 55 years.

Treatment:
Patients received chemotherapy with irinotecan and biologic therapy with bevacizumab.

Toxicities:
The most severe toxicities were of grade 3 and included neutropenia, diarrhea, and cramping. Grade 2 alopecia and nausea were also reported.

Results:
The median overall survival was 13.8 months.

Correspondence: Dr. Ying Liu; email: [email protected]



Back